Q Jiang, X Chen, X Tian, J Zhang, S Xue, Y Jiang, T Liu… - Phytomedicine, 2022 - Elsevier
Background Doxorubicin (DOX) is a powerful anti-tumor anthracycline drug. However, its
clinical use is limited due to the side effect of cardiotoxicity. Tanshinone I (Tan I) is one of the …